F Pannuti

4.6k total citations
122 papers, 1.5k citations indexed

About

F Pannuti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, F Pannuti has authored 122 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 21 papers in Genetics. Recurrent topics in F Pannuti's work include Cancer Treatment and Pharmacology (51 papers), Estrogen and related hormone effects (20 papers) and Chemotherapy-induced cardiotoxicity and mitigation (19 papers). F Pannuti is often cited by papers focused on Cancer Treatment and Pharmacology (51 papers), Estrogen and related hormone effects (20 papers) and Chemotherapy-induced cardiotoxicity and mitigation (19 papers). F Pannuti collaborates with scholars based in Italy, United States and New Zealand. F Pannuti's co-authors include Andrea Martoni, Elena Strocchi, Bruna Angelelli, C. M. Camaggi, M. Guaraldi, E Piana, Carlo Maurizio Camaggi, S Tanneberger, Barbara Melotti and M. A. Pacciarini and has published in prestigious journals such as Pain, Annals of Oncology and European Journal of Cancer.

In The Last Decade

F Pannuti

118 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Pannuti Italy 23 766 294 233 226 213 122 1.5k
Flora A. Ukoli United States 21 230 0.3× 174 0.6× 319 1.4× 228 1.0× 248 1.2× 50 1.3k
Susannah Stanway United Kingdom 16 681 0.9× 386 1.3× 351 1.5× 293 1.3× 242 1.1× 38 1.5k
Luigi Santoro Italy 26 679 0.9× 589 2.0× 318 1.4× 143 0.6× 160 0.8× 77 2.3k
Kerryn W. Reding United States 23 604 0.8× 235 0.8× 175 0.8× 193 0.9× 297 1.4× 85 1.5k
Susan Dent Canada 27 1.1k 1.4× 259 0.9× 313 1.3× 271 1.2× 315 1.5× 81 2.1k
Ashley S. Felix United States 28 741 1.0× 218 0.7× 146 0.6× 280 1.2× 359 1.7× 102 2.7k
Paul Carter United Kingdom 22 473 0.6× 165 0.6× 187 0.8× 337 1.5× 275 1.3× 35 1.7k
Peter S. Bunting Canada 25 500 0.7× 111 0.4× 695 3.0× 109 0.5× 445 2.1× 61 2.4k
E. Terzoli Italy 29 1.9k 2.4× 173 0.6× 644 2.8× 208 0.9× 342 1.6× 102 2.8k
Shirley M. Bluethmann United States 15 1.0k 1.3× 356 1.2× 384 1.6× 191 0.8× 82 0.4× 33 2.1k

Countries citing papers authored by F Pannuti

Since Specialization
Citations

This map shows the geographic impact of F Pannuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Pannuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Pannuti more than expected).

Fields of papers citing papers by F Pannuti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Pannuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Pannuti. The network helps show where F Pannuti may publish in the future.

Co-authorship network of co-authors of F Pannuti

This figure shows the co-authorship network connecting the top 25 collaborators of F Pannuti. A scholar is included among the top collaborators of F Pannuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Pannuti. F Pannuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dekel, Boaz Gedaliahu Samolsky, et al.. (2014). Transdermal opioids for cancer pain control in patients with renal impairment. Journal of Opioid Management. 10(2). 85–93. 20 indexed citations
2.
Martoni, Andrea, Bruna Angelelli, M. Guaraldi, Elena Strocchi, & F Pannuti. (1996). An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens. European Journal of Cancer. 32(1). 82–85. 17 indexed citations
3.
Martoni, A., et al.. (1995). CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study. European Journal of Cancer. 31(10). 1615–1621. 29 indexed citations
4.
Tanneberger, S & F Pannuti. (1993). Disillusionments and hopes in the field of biological response modifiers.. PubMed. 13(1). 185–92. 5 indexed citations
5.
Martoni, Andrea, et al.. (1993). A Phase II Study of Carboplatin and Cyclophosphamide in Advanced Ovarian Carcinoma. Journal of Chemotherapy. 5(1). 47–51. 10 indexed citations
6.
Camaggi, Carlo Maurizio, et al.. (1992). High-performance liquid chromatographic analysis of idarubicin and fluorescent metabolites in biological fluids. Cancer Chemotherapy and Pharmacology. 30(4). 303–306. 21 indexed citations
7.
Martoni, Andrea, Barbara Melotti, M. Guaraldi, & F Pannuti. (1991). Activity of high-dose epirubicin in advanced non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. 27(10). 1231–1234. 26 indexed citations
9.
Periti, P, F Pannuti, G. Robustelli della Cuna, et al.. (1991). Combination Chemotherapy with Cyclophosphamide, Fluorouracil, and Either Epirubicin or Mitoxantrone: a Comparative Randomized Multicenter Study in Metastatic Breast Carcinoma. Cancer Investigation. 9(3). 249–255. 11 indexed citations
11.
Strocchi, Elena, C. M. Camaggi, Andrea Martoni, et al.. (1991). Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses. Cancer Chemotherapy and Pharmacology. 27(6). 451–455. 5 indexed citations
12.
Zamagni, C., et al.. (1991). 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC Combination) in Advanced Breast Cancer. Journal of Chemotherapy. 3(2). 126–129. 6 indexed citations
13.
Martoni, Andrea, et al.. (1990). Cisplatinum plus Epirubicin Alternated with Cyclophosphamide plus 5-Fluorouracil in Ovarian Cancer. Journal of Chemotherapy. 2(1). 62–66. 4 indexed citations
14.
Martoni, A., Barbara Melotti, M. Guaraldi, et al.. (1990). High-dose epiribicin for untreated patients with advanced tumours: a phase I study. European Journal of Cancer and Clinical Oncology. 26(11-12). 1137–1140. 16 indexed citations
15.
Martoni, Andrea, et al.. (1990). Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer. Oncology. 47(5). 427–432. 24 indexed citations
17.
Camaggi, C. M., et al.. (1988). HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluids. Cancer Chemotherapy and Pharmacology. 21(3). 216–20. 37 indexed citations
18.
Camaggi, C. M., et al.. (1988). Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. Cancer Chemotherapy and Pharmacology. 21(3). 221–8. 91 indexed citations
20.
Pannuti, F. (1978). Surgical adjuvant hormone therapy in breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 48(7). 680–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026